QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
NASDAQ:CALA

Calithera Biosciences Stock Competitors

$0.21
+0.01 (+5.05%)
(As of 05/19/2022 04:00 PM ET)
Add
Compare
Today's Range
$0.18
$0.22
50-Day Range
$0.16
$0.63
52-Week Range
$0.15
$2.59
Volume
3.35 million shs
Average Volume
2.75 million shs
Market Capitalization
$16.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.64

Calithera Biosciences (NASDAQ:CALA) Vs. LTRN, AKTX, EYEN, DMAC, BCEL, AKBA, MTEM, ONCY, BOLT, and SEEL

Should you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include Lantern Pharma (LTRN), Akari Therapeutics (AKTX), Eyenovia (EYEN), DiaMedica Therapeutics (DMAC), Atreca (BCEL), Akebia Therapeutics (AKBA), Molecular Templates (MTEM), Oncolytics Biotech (ONCY), Bolt Biotherapeutics (BOLT), and Seelos Therapeutics (SEEL). These companies are all part of the "pharmaceutical preparations" industry.

Calithera Biosciences vs.

Calithera Biosciences (NASDAQ:CALA) and Lantern Pharma (NASDAQ:LTRN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk.

Lantern Pharma has lower revenue, but higher earnings than Calithera Biosciences. Lantern Pharma is trading at a lower price-to-earnings ratio than Calithera Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calithera Biosciences$9.75 million1.68-$115.09 million-$1.44-0.14
Lantern PharmaN/AN/A-$12.36 million-$1.26-4.76

55.8% of Calithera Biosciences shares are held by institutional investors. Comparatively, 34.2% of Lantern Pharma shares are held by institutional investors. 11.9% of Calithera Biosciences shares are held by insiders. Comparatively, 30.3% of Lantern Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Calithera Biosciences had 5 more articles in the media than Lantern Pharma. MarketBeat recorded 5 mentions for Calithera Biosciences and 0 mentions for Lantern Pharma. Lantern Pharma's average media sentiment score of 0.84 beat Calithera Biosciences' score of -0.23 indicating that Lantern Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Calithera Biosciences Neutral
Lantern Pharma Positive

Calithera Biosciences has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500. Comparatively, Lantern Pharma has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500.

Lantern Pharma's return on equity of -19.12% beat Calithera Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Calithera Biosciences N/A -141.76% -76.15%
Lantern Pharma N/A -19.12% -18.48%

Calithera Biosciences received 330 more outperform votes than Lantern Pharma when rated by MarketBeat users. However, 81.82% of users gave Lantern Pharma an outperform vote while only 69.04% of users gave Calithera Biosciences an outperform vote.

CompanyUnderperformOutperform
Calithera BiosciencesOutperform Votes
339
69.04%
Underperform Votes
152
30.96%
Lantern PharmaOutperform Votes
9
81.82%
Underperform Votes
2
18.18%

Calithera Biosciences presently has a consensus price target of $2.50, indicating a potential upside of 1,101.92%. Lantern Pharma has a consensus price target of $32.50, indicating a potential upside of 441.67%. Given Calithera Biosciences' higher probable upside, equities research analysts clearly believe Calithera Biosciences is more favorable than Lantern Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Calithera Biosciences
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Lantern Pharma
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Lantern Pharma beats Calithera Biosciences on 8 of the 15 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CALA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

Calithera Biosciences (NASDAQ:CALA) vs. Its Competitors

MetricCalithera BiosciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$16.37M$5.72B$4.37B$5.68B
Dividend YieldN/A2.48%2.15%3.16%
P/E Ratio-0.1411.2812.2513.08
Price / Sales1.68340.952,255.16103.12
Price / CashN/A20.3422.6383.74
Price / Book-5.203.884.104.27
Net Income-$115.09M$190.38M$164.19M$240.14M
7 Day Performance29.11%7.94%5.44%4.01%
1 Month Performance-42.22%-17.08%-15.54%-12.85%
1 Year Performance-90.33%-45.93%-29.45%-25.88%

Calithera Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LTRN
Lantern Pharma
2.1583 of 5 stars
$6.00
+5.3%
$32.50
+441.7%
-60.8%$64.99MN/A-4.7614
AKTX
Akari Therapeutics
1.2398 of 5 stars
$1.09
-7.6%
N/A-38.5%$64.69MN/A-2.669Gap Down
EYEN
Eyenovia
2.1781 of 5 stars
$2.02
-1.5%
$9.00
+345.5%
-57.6%$64.03M$14M-3.7443Gap Down
DMAC
DiaMedica Therapeutics
1.5265 of 5 stars
$2.42
+5.2%
$17.50
+623.1%
-66.0%$63.99MN/A-4.1714
BCEL
Atreca
2.1898 of 5 stars
$1.69
-3.4%
$18.00
+965.1%
-81.7%$63.81MN/A-0.58134Analyst Report
Analyst Revision
News Coverage
Gap Down
AKBA
Akebia Therapeutics
2.1648 of 5 stars
$0.35
+3.0%
$1.75
+405.8%
-90.5%$63.50M$213.58M-0.22426Analyst Report
MTEM
Molecular Templates
2.6064 of 5 stars
$1.12
+2.8%
$6.75
+502.7%
-87.3%$63.06M$38.70M-0.81261Earnings Report
Insider Buying
Short Interest ↑
ONCY
Oncolytics Biotech
1.7048 of 5 stars
$1.09
-2.7%
$9.00
+725.7%
-61.0%$62.68MN/A-2.8726Gap Down
BOLT
Bolt Biotherapeutics
2.1914 of 5 stars
$1.66
+5.7%
$30.33
+1,727.3%
-91.8%$62.20M$1.26M-0.6391Analyst Report
Analyst Revision
News Coverage
SEEL
Seelos Therapeutics
1.9664 of 5 stars
$0.58
+1.7%
$7.50
+1,182.7%
-82.1%$62.03M$380K0.0015News Coverage
MEIP
MEI Pharma
2.1236 of 5 stars
$0.47
flat
$5.25
+1,026.6%
-82.3%$61.97M$25.53M-0.7976Short Interest ↑
News Coverage
QLI
Qilian International Holding Group
1 of 5 stars
$1.73
+4.8%
N/A-63.1%$61.85M$57.10M0.00283
GMTX
Gemini Therapeutics
2.5765 of 5 stars
$1.43
-1.4%
$6.90
+382.5%
-86.9%$61.82MN/A-0.9131Gap Down
BLRX
BioLineRx
1.25 of 5 stars
$1.30
+1.6%
N/A-58.8%$61.74MN/A-2.3138Analyst Revision
ETNB
89bio
2.2457 of 5 stars
$2.99
+1.0%
$41.43
+1,285.6%
-86.9%$60.85MN/A-0.6041Analyst Report
Analyst Revision
Gap Down
NHWK
NightHawk Biosciences
1.9364 of 5 stars
$2.36
+4.0%
$14.33
+507.3%
-64.5%$60.53M$2.11M-1.6639Earnings Report
LBPH
Longboard Pharmaceuticals
1.7765 of 5 stars
$4.40
+5.8%
$14.00
+218.2%
-53.4%$59.78MN/A-2.3521Short Interest ↓
News Coverage
DBTX
Decibel Therapeutics
2.2698 of 5 stars
$2.32
+3.6%
$18.43
+694.3%
-66.9%$57.92MN/A-1.0662Analyst Report
Short Interest ↑
News Coverage
Gap Up
FOXW
FoxWayne Enterprises Acquisition
0.3333 of 5 stars
$10.07
flat
N/AN/A$57.90MN/A0.001
MREO
Mereo BioPharma Group
2.1098 of 5 stars
$0.49
+2.1%
$8.67
+1,668.7%
-84.9%$57.32M$50.14M0.0038
INFI
Infinity Pharmaceuticals
1.6398 of 5 stars
$0.64
+3.2%
$7.00
+996.5%
-79.8%$56.92M$1.86M-1.2323Short Interest ↑
News Coverage
HEPA
Hepion Pharmaceuticals
1.7581 of 5 stars
$0.75
+4.2%
$3.50
+369.8%
-56.5%$56.79MN/A0.0013
MDNA
Medicenna Therapeutics
1.825 of 5 stars
$1.02
-3.8%
$9.00
+782.4%
-69.4%$56.76MN/A-2.6813Gap Down
NOVN
Novan
1.9848 of 5 stars
$2.92
+12.3%
$20.00
+584.9%
N/A$55.91M$2.96M-1.5529Earnings Report
Analyst Revision
RDHL
RedHill Biopharma
1.6864 of 5 stars
$1.05
-1.9%
$17.25
+1,542.9%
-83.9%$55.32M$85.76M-0.50201Upcoming Earnings
ATNX
Athenex
1.9631 of 5 stars
$0.49
+8.8%
$4.00
+709.6%
-90.4%$55.26M$120.18M-0.28652
FSTX
F-star Therapeutics
1.9917 of 5 stars
$2.56
+7.6%
$29.20
+1,040.6%
-65.2%$55.19M$21.17M-1.6684Analyst Report
Short Interest ↑
Analyst Revision
ORGS
Orgenesis
0.25 of 5 stars
$2.10
-0.5%
N/A-56.3%$52.12M$35.50M6.56111Upcoming Earnings
High Trading Volume
LBPS
4D pharma
2.0333 of 5 stars
$3.17
-3.4%
$40.00
+1,161.8%
-69.5%$52.09M$720K0.0092Positive News
Gap Down
LFVN
LifeVantage
1.5431 of 5 stars
$4.11
+0.2%
N/A-49.4%$51.75M$220.18M5.87263Ex-Dividend
BYSI
BeyondSpring
1.5231 of 5 stars
$1.32
+7.3%
$30.00
+2,172.7%
-87.9%$51.39M$1.35M-0.8091
NEXI
NexImmune
2.4431 of 5 stars
$2.20
+2.8%
$10.00
+354.5%
-88.2%$50.25MN/A-0.8774Earnings Report
Positive News
CRVS
Corvus Pharmaceuticals
2.6798 of 5 stars
$1.07
+0.9%
$6.38
+495.8%
-58.9%$49.81MN/A-1.1928
KALA
Kala Pharmaceuticals
2.1381 of 5 stars
$0.68
-2.8%
$3.38
+394.9%
-87.1%$49.51M$11.24M-0.32192Earnings Report
Analyst Report
VCNX
Vaccinex
1.6331 of 5 stars
$1.16
+1.8%
N/A-50.0%$49.49M$900K-1.7839Short Interest ↓
ATXS
Astria Therapeutics
1.9514 of 5 stars
$3.80
-3.3%
$16.33
+329.8%
-65.0%$49.47MN/A-0.4829Earnings Report
Short Interest ↓
Analyst Revision
RPHM
Reneo Pharmaceuticals
2.2833 of 5 stars
$2.02
-4.3%
$26.80
+1,226.7%
-74.8%$49.41MN/A-1.0624Analyst Upgrade
Short Interest ↑
High Trading Volume
SNSE
Sensei Biotherapeutics
2.1183 of 5 stars
$1.61
flat
$12.50
+676.4%
-82.6%$49.31MN/A-1.2156Analyst Upgrade
CNTB
Connect Biopharma
1.5915 of 5 stars
$0.88
+2.3%
$24.67
+2,713.9%
-94.8%$48.28MN/A0.0062Positive News
Gap Up
BFRI
Biofrontera
1.825 of 5 stars
$2.80
+7.3%
$15.50
+453.6%
N/A$47.89M$24.10M0.0069
LRMR
Larimar Therapeutics
1.9098 of 5 stars
$2.69
+3.1%
$5.50
+104.5%
-80.1%$47.64MN/A-1.0031Analyst Revision
News Coverage
Gap Up
ITRM
Iterum Therapeutics
2.0181 of 5 stars
$0.26
+4.0%
$0.70
+167.3%
-77.3%$47.52M$40K13.0113Earnings Report
Positive News
Gap Down
GRTX
Galera Therapeutics
1.9065 of 5 stars
$1.77
+4.1%
$11.75
+563.8%
-78.4%$47.43MN/A-0.6030Earnings Report
Analyst Downgrade
Short Interest ↑
NLTX
Neoleukin Therapeutics
1.9915 of 5 stars
$1.11
+2.8%
$23.50
+2,017.1%
-90.1%$47.18MN/A-1.0091Short Interest ↑
News Coverage
SPRO
Spero Therapeutics
2.6664 of 5 stars
$1.44
flat
$37.33
+2,492.6%
-89.6%$47.17M$18.26M-0.44146Earnings Report
Analyst Report
Analyst Revision
Gap Up
AQST
Aquestive Therapeutics
1.7048 of 5 stars
$1.12
-4.3%
$11.00
+882.1%
-67.1%$46.94M$50.83M-0.64157Analyst Report
TYME
Tyme Technologies
1.3381 of 5 stars
$0.27
+3.8%
N/A-80.1%$46.84MN/A-1.9417News Coverage
RZLT
Rezolute
2.7698 of 5 stars
$3.00
+4.9%
$22.25
+641.7%
-56.7%$46.67MN/A-0.9526Analyst Report
Positive News
ATNF
180 Life Sciences
1.4332 of 5 stars
$1.36
-4.9%
$11.00
+708.8%
-80.9%$46.36MN/A0.002
PRQR
ProQR Therapeutics
1.7656 of 5 stars
$0.64
+1.6%
$7.43
+1,057.1%
-90.1%$45.77M$1.60M-0.601,504Gap Down
This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.